ING Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.34M Buy
308,300
+124,100
+67% +$2.15M 0.03% 244
2025
Q1
$4.03M Buy
+184,200
New +$4.03M 0.03% 257